HPV vaccine Current Events | HPV vaccine News | 2
|
| Page
2 of
34 |
671 Results |
|
|
|
Sort By:
Page Views | Date |
HPV-vaccine may prevent preterm births
Chronic human papilloma virus (HPV)-infections can lead to cellular changes in the cervix that can be a pre-stage to cervical cancer. Surgical treatment of these pre-stages gives an increased risk of preterm birth in subsequent pregnancies. view more (2009-03-17)
HPV LINKED TO CERVICAL LESIONS
Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study BMJ Volume 325, pp 572 - 576 Infection with humanpapillomavirus (HPV) is linked to an increased... view more... (2002-09-10)
Both Latino and non-Latino women likely to accept HPV vaccination for selves and children
Most women responding to a survey conducted at Massachusetts General Hospital (MGH) clinics indicated they would be willing to be vaccinated against the human papillomavirus (HPV) and to have their daughters and even sons vaccinated in order to prevent cancer in their children. view more (2009-03-09)
A New Startup Fund Called EMERTEC
CEA (the French Atomic Energy Commission) and the Caisse des Dépôts et Consignations (CDC) promoted the setup of EMERTEC, a new startup fund for investing in new high technology companies on emerging, booming markets. The shares issue has been open since January 2000 and has already raised 120 million francs out of the 160-million... view more... (2000-06-20)
Human Papilloma virus as a predictor of cervical cancer
Two studies published in this week's issue of THE LANCET suggest that the detection of the amount of human papillomavirus (HPV) could help identify women at risk of cervical cancer. Infection with certain types of HPV - which is common among young women - increases the risk of cervical cancer. However, less than 1% of young women positive for... view more... (2000-06-22)
Oestrogen may be associated with virus (HPV) infection implicated in cervical cancer
The female hormone oestrogen may have a role in HPV viral infection, strains of which are implicated in cervical cancer, shows research in Sexually Transmitted Infections. view more (2002-06-17)
What does the public really know about HPV?
Human papillomaviruses (HPV) are the most common sexually transmitted infections in the United States, and certain "high risk" types have been shown to cause cervical cancer. view more (2006-11-13)
A missed shot: The failure of HPV vaccination state requirements
In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrounding the human papillomavirus (HPV) vaccine debate, and its effects on ethical and public health issues. view more (2007-11-02)
Vaccination and testing for the human papilloma virus could eradicate cervical cancer
Cervical cancer could be eradicated within the next 50 years if countries implement national screening programmes based on detection of the human papilloma virus (HPV), which causes the disease, together with vaccination programmes against the virus, according to a cervical cancer screening expert. view more (2009-09-24)
Vaccinating boys against human papillomavirus not cost-effective
Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. view more (2009-10-09)
Cervical cancer prevention should focus on vaccinating adolescent girls
The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by... view more... (2008-08-21)
'WAIT AND SEE' POLICY' SUGGESTED FOR WOMEN WITH ABNORMAL CERVICAL SMEARS IN PRESENCE of HIGH-RISK HUMAN PAPILLOMAVIRUS (p 1782)
Women with abnormal cervical smears (mild to moderate dyskaryosis) and who are positive for the high-risk form of human papillomavirus (HR-HPV) should not be treated for at least 6 months after cytological screening to see if the virus disappears, suggest authors of a research letter in this week's issue of THE LANCET. If viral clearance occurs,... view more... (2001-11-21)
HPV testing could be future strategy for primary screening for cervical cancer (pp 1866, 1871)
Embargoed 0001 h (London time) 5 December 2003. Authors of a UK study in this week's issue of THE LANCET propose a new approach for cervical cancer screening. Testing for the human papilloma virus (HPV)-the main cause of cervical cancer-could be the primary screening tool, with cytology reserved for women who test positive for HPV. HPV testing... view more... (2003-12-03)
Self-collection of specimens for HPV testing
n this Research letter, Dr. Gina Ogilvie and colleagues investigate the feasibility of self-collection of specimens for HPV testing among women who may not make full use of cytology screening programs (e.g., women who are homeless or who are involved in the sex trade) and are thus at increased risk of cervical cancer. view more (2007-08-28)
Parents need to be educated about HPV vaccinations for daughters
Parents of young girls may soon be offered the opportunity to have their daughters immunised against a sexually transmitted virus that is the major cause of cervical cancer, the 4th International Conference on Teenage and Young Adult Cancer Medicine heard today. view more (2006-03-30)
Rare head and neck cancer linked to HPV, study finds
An increase in cases of a rare type of head and neck cancer appears to be linked to HPV, or human papillomavirus, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. view more (2009-10-08)
Fears of promiscuity pose barrier to cervical cancer vaccinations
The public's concerns about costs and increased promiscuity among teenagers appear to be hindering use of a vaccine against the human papilloma virus (HPV) to prevent life-threatening diseases, according to a study by researchers at Yale School of Public Health. view more (2008-12-18)
Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening
A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. view more (2008-10-31)
Study: HPV test beats Pap in detecting cervical cancer
A new study led by McGill University researchers shows that the human papillomavirus (HPV) screening test is far more accurate than the traditional Pap test in detecting cervical cancer. view more (2007-10-18)
Painkillers may threaten power of vaccines
With flu-shot season in full swing and widespread anticipation of the HPV vaccine to prevent cervical cancer, a new University of Rochester study suggests that using common painkillers around the time of vaccination might not be a good idea. view more (2006-11-29)
|
|
| Page
2 of
34 |
671 Results |
|
|
|
Sort By:
Page Views | Date |
|
